Literature DB >> 6429705

Effect of nicotine on the tobacco withdrawal syndrome.

J R Hughes, D K Hatsukami, R W Pickens, D Krahn, S Malin, A Luknic.   

Abstract

This study tested the ability of nicotine to alleviate the tobacco withdrawal syndrome. Signs and symptoms of tobacco withdrawal were measured in 100 smokers who fulfilled DSM-III criteria for tobacco dependence and a past history of tobacco withdrawal. After 2 evenings of baseline measurement, subjects were randomly assigned to receive either nicotine or placebo gum in a double blind manner. Subjects then stopped smoking, chewed gum freely, and returned on the 1st, 2nd, and 4th evenings of abstinence for further measurement. Nicotine reduced the increase in irritability, anxiety, difficulty concentrating, restlessness, impatience, and somatic complaints that subjects reported after cessation. Reductions in these withdrawal symptoms by nicotine were confirmed by ratings of significant others and by subjects' scores on the Profile of Mood States. Nicotine did not reduce the increases in cigarette craving, hunger, eating, insomnia, tremulousness , or supine heart rate after cessation. The effects of nicotine occurred immediately and persisted throughout the study. Although many subjects correctly identified their drug group, the efficacy of the gum was independent of subjects' identifications of drug. The relief of tobacco withdrawal by nicotine gum suggests that the tobacco withdrawal syndrome is caused, in part, by nicotine deprivation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429705     DOI: 10.1007/bf00427428

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Pharmacological and psychological determinants of smoking. A New York University honors program lecture.

Authors:  S Schachter
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

2.  Increasing the validity of self-reports of smoking behavior in children.

Authors:  R I Evans; W B Hansen; M B Mittelmark
Journal:  J Appl Psychol       Date:  1977-08

Review 3.  Cigarette smoking: a dependence on high-nicotine boli.

Authors:  M A Russell; C Feyerabend
Journal:  Drug Metab Rev       Date:  1978       Impact factor: 4.518

4.  Changes in behavioral and physiological activation induced by cigarette smoking in habitual smokers.

Authors:  A L Myrsten; B Post; M Frankenhaeuser; G Johansson
Journal:  Psychopharmacologia       Date:  1972

5.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

6.  Mazindol: its efficacy and mode of action in generating weight loss.

Authors:  W G Johnson; J R Hughes
Journal:  Addict Behav       Date:  1979       Impact factor: 3.913

Review 7.  The nature and determinants of adjunctive behavior.

Authors:  J L Falk
Journal:  Physiol Behav       Date:  1971-05

Review 8.  Clinical use of nicotine chewing-gum.

Authors:  M A Russell; M Raw; M J Jarvis
Journal:  Br Med J       Date:  1980-06-28

9.  Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia.

Authors:  M A Carskadon; W C Dement; M M Mitler; C Guilleminault; V P Zarcone; R Spiegel
Journal:  Am J Psychiatry       Date:  1976-12       Impact factor: 18.112

10.  The use of nicotine gum during cessation of smoking.

Authors:  N G Schneider; P Popek; M E Jarvik; E R Gritz
Journal:  Am J Psychiatry       Date:  1977-04       Impact factor: 18.112

View more
  74 in total

1.  Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers.

Authors:  C L Masson; D G Gilbert
Journal:  J Behav Med       Date:  1999-12

2.  Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

3.  Stress and arousal in sedative and stimulant cigarette smokers.

Authors:  S T O'Neill; A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

Review 5.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

6.  Training physicians about smoking cessation: a controlled trial in private practice.

Authors:  S R Cummings; R J Richard; C L Duncan; B Hansen; R Vander Martin; B Gerbert; T J Coates
Journal:  J Gen Intern Med       Date:  1989 Nov-Dec       Impact factor: 5.128

7.  Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.

Authors:  K O Fagerström; N G Schneider; E Lunell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Nicotine or tar titration in cigarette smoking behavior?

Authors:  M Hasenfratz; B Baldinger; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  "I cannot live without my vape": Electronic cigarette user-identified indicators of vaping dependence.

Authors:  Eric K Soule; Joseph G L Lee; Kathleen L Egan; Kendall M Bode; Abigail C Desrosiers; Mignonne C Guy; Alison Breland; Pebbles Fagan
Journal:  Drug Alcohol Depend       Date:  2020-02-05       Impact factor: 4.492

10.  Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study.

Authors:  Rebecca L Ashare; E Paul Wileyto; Kosha Ruparel; Patricia M Goelz; Ryan D Hopson; Jeffrey N Valdez; Ruben C Gur; James Loughead; Caryn Lerman
Journal:  Drug Alcohol Depend       Date:  2013-09-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.